Zunveyl

Active Ingredient(s): Benzgalantamine
FDA Approved: * July 26, 2024
Pharm Company: * ALPHA COGNITION INC
Category: Alzheimers / Dementia
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zunveyl 5 mg Oral Tablet, Delayed Release
NDC: 84054-005
Labeler:
Alpha Cognition, Inc.
Zunveyl 10 mg Oral Tablet, Delayed Release
NDC: 84054-010
Labeler:
Alpha Cognition, Inc.
Zunveyl 15 mg Oral Tablet, Delayed Release
NDC: 84054-015
Labeler:
Alpha Cognition, Inc.